Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 2:21 PM ET

Date/Time Source News Release
04/26/2025 10:00 AM EDT GlobeNewswire Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
04/23/2025 08:00 AM EDT GlobeNewswire Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
04/15/2025 04:13 PM EDT GlobeNewswire Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
04/10/2025 04:05 PM EDT GlobeNewswire Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
03/19/2025 08:00 AM EDT GlobeNewswire Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
03/05/2025 08:00 AM EST GlobeNewswire Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
02/26/2025 08:00 AM EST GlobeNewswire Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
02/05/2025 08:00 AM EST GlobeNewswire Protara Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
01/13/2025 08:00 AM EST GlobeNewswire Protara Highlights Recent Updates and Anticipated 2025 Milestones
01/08/2025 08:00 AM EST GlobeNewswire Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Page

Additional News

As of April 30, 2025 • 2:21 PM ET

Date/Time Source News Release
04/15/2025 04:23 PM EDT SeekingAlpha Protara Therapeutics appoints Leonardo Nicacio as chief medical officer
04/09/2025 12:00 PM EDT Zacks Protara Therapeutics (TARA) Moves to Buy: Rationale Behind the Upgrade
03/28/2025 05:10 PM EDT SeekingAlpha Protara Therapeutics: Speculative Buy On Promising TARA-002 Trial Results
03/07/2025 09:17 AM EST Baystreet From Clinical Trials to the Market: Cancer Stocks With Big Potential in 2025
03/07/2025 04:31 AM EST US Earnings Reports Expected earnings - Protara Therapeutics Inc.
03/05/2025 09:02 AM EST SeekingAlpha Protara Therapeutics reports Q4 results
01/11/2025 01:16 PM EST Stock Traders Daily (TARA) Proactive Strategies
12/14/2024 08:30 AM EST SeekingAlpha Protara Therapeutics: Rising From The Ashes
12/10/2024 05:00 PM EST SeekingAlpha Protara Therapeutics: Carving New Roads In Bladder Cancer
12/10/2024 03:55 PM EST SeekingAlpha Protara: Six-Month NMIBC Treatment Data Bodes Well For Mid-2025 Catalyst
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.